Inventor · disambiguated record
Thomas Wegge
Also filed as: WEGGE THOMAS
38 granted patents·24 pending applications·372 citations·filing 2004–2025
97Inventor score
Files withASCENDIS PHARMA BONE DISEASES AS16ASCENDIS PHARMA AS10ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S7ASCENDIS PHARMA GROWTH DISORDERS AS7HERSEL ULRICH5
Top patents by PatentIndex Score
62 records- 0197US9056126B2Hydrogel formulationsHERSEL ULRICH·Filed 2011·Granted Jun 16, 2015·59 cites·23 claims
- 0296US11890326B2Controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2022·Granted Feb 6, 2024·5 cites·11 claims
- 0396US11793861B2PTH prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2022·Granted Oct 24, 2023·5 cites·15 claims
- 0495US11918628B2Controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Granted Mar 5, 2024·4 cites·9 claims
- 0595US11857603B2PTH compounds with low peak-to-trough ratiosASCENDIS PHARMA BONE DISEASES AS·Filed 2022·Granted Jan 2, 2024·5 cites·12 claims
- 0695US8906847B2Prodrug comprising a drug linker conjugateCLEEMANN FELIX·Filed 2009·Granted Dec 9, 2014·86 cites·37 claims
- 0794US9919033B2Dry growth hormone composition transiently linked to a polymer carrierASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2016·Granted Mar 20, 2018·10 cites·20 claims
- 0892US11759504B2PTH compounds with low peak-to-trough ratiosASCENDIS PHARMA BONE DISEASES AS·Filed 2017·Granted Sep 19, 2023·6 cites·12 claims
- 0991US9511122B2Dry growth hormone composition transiently linked to a polymer carrierRASMUSSEN GRETHE NØRSKOV·Filed 2010·Granted Dec 6, 2016·16 cites·36 claims
- 1090US12133883B2Polymeric hGH prodrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2020·Granted Nov 5, 2024·2 cites·21 claims
- 1190US10960053B2PEGylated recombinant human growth hormone compoundsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2018·Granted Mar 30, 2021·5 cites·13 claims
- 1290US8377917B2Polymeric prodrug with a self-immolative linkerCOMPLEX BIOSYSTEMS GMBH·Filed 2005·Granted Feb 19, 2013·23 cites·36 claims
- 1389US10799563B2Polymeric hGH prodrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2015·Granted Oct 13, 2020·10 cites·21 claims
- 1489US2025127797A1Prodrug comprising a drug-linker conjugateASCENDIS PHARMA AS·Filed 2024·Application pending·0 cites
- 1589US2025268988A1PTH ProdrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2024·Application pending·0 cites
- 1688US11224661B2Controlled-release CNP agonists with increased NEP stabilityASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2017·Granted Jan 18, 2022·7 cites·13 claims
- 1788US10682395B2Dry growth hormone composition transiently linked to a polymer carrierASCENDIS PHARMA ENDOCRINOLOGY DIV·Filed 2018·Granted Jun 16, 2020·5 cites·22 claims
- 1888US9272048B2PEGylated recombinant human growth hormone compoundsRAU HARALD·Filed 2009·Granted Mar 1, 2016·15 cites·37 claims
- 1987US12295989B2Controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2024·Granted May 13, 2025·0 cites·5 claims
- 2087US12214020B2PTH prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Granted Feb 4, 2025·0 cites·9 claims
- 2187US7968085B2Hydrogel formulationsASCENDIS PHARMA AS·Filed 2004·Granted Jun 28, 2011·37 cites·16 claims
- 2286US2025032587A1Novel Polymeric hGH ProdrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2024·Application pending·0 cites
- 2385US11311604B2Controlled-release CNP agonists with low NPR-C bindingASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2017·Granted Apr 26, 2022·6 cites·10 claims
- 2485US10098930B2PEGylated Recombinant Human Growth Hormone CompoundsASCENDIS PHARMA GROWTH DISORDERS DIV A/S·Filed 2016·Granted Oct 16, 2018·10 cites·12 claims
- 2585US9457066B2Prodrugs comprising an insulin linker conjugateSANOFI AVENTIS DEUTSCHLAND·Filed 2015·Granted Oct 4, 2016·6 cites·24 claims
- 2685US2024041897A1Prodrug comprising a drug linker conjugateASCENDIS PHARMA AS·Filed 2023·Application pending·0 cites
- 2782US2022331334A1Prodrug Comprising a Drug-Linker ConjugateASCENDIS PHARMA AS·Filed 2022·Application pending·0 cites
- 2881US2023321198A1Dosage Regimen for a Controlled-Release PTH CompoundASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Application pending·0 cites
- 2980US9265723B2Long acting insulin compositionSPROGOE KENNETT·Filed 2010·Granted Feb 23, 2016·11 cites·50 claims
- 3080US2024173385A1PTH Compounds with Low Peak-To-Trough RatiosASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Application pending·0 cites
- 3179US10029015B2Hydrogel formulationsASCENDIS PHARMA AS·Filed 2015·Granted Jul 24, 2018·2 cites·22 claims
- 3279US9872864B2Sustained release composition of prostacyclinSPROGØE KENNETT·Filed 2012·Granted Jan 23, 2018·6 cites·13 claims
- 3377US10729778B2Carrier-linked treprostinil prodrugsHERSEL ULRICH·Filed 2017·Granted Aug 4, 2020·1 cites·24 claims
- 3477US2022008516A1PTH ProdrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2021·Application pending·0 cites
- 3577US2025302924A1Controlled-Release PTH CompoundASCENDIS PHARMA BONE DISEASES AS·Filed 2025·Application pending·0 cites
- 3676US2020046725A1Prodrug Comprising a Drug Linker ConjugateASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 3775US9561287B2Carrier-linked treprostinil prodrugsHERSEL ULRICH·Filed 2012·Granted Feb 7, 2017·3 cites·28 claims
- 3875US8980242B2Aliphatic prodrug linkerVETTER DIRK·Filed 2006·Granted Mar 17, 2015·3 cites·50 claims
- 3973US12274737B2PEGylated recombinant human growth hormone compoundsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2021·Granted Apr 15, 2025·0 cites·18 claims
- 4073US9913912B2Carrier-linked prostanoid prodrugsASCENDIS PHARMA AS·Filed 2013·Granted Mar 13, 2018·2 cites·21 claims
- 4173US2023116746A1Cnp prodrugsASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2022·Application pending·0 cites
- 4271US9238686B2Polymeric prodrug with self-immolative linkerASCENDIS PHARMA GMBH·Filed 2013·Granted Jan 19, 2016·2 cites·28 claims
- 4371US2020360487A1Pth prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2020·Application pending·0 cites
- 4471US2020376089A1Pth prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2020·Application pending·0 cites
- 4568US12226457B2Dry growth hormone composition transiently linked to a polymer carrierASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2020·Granted Feb 18, 2025·0 cites·39 claims
- 4668US7879588B2Protein-proteophore complexesASCENDIS PHARMA AS·Filed 2004·Granted Feb 1, 2011·19 cites·10 claims
- 4766US9138462B2Prodrugs comprising an insulin linker conjugateRAU HARALD·Filed 2010·Granted Sep 22, 2015·1 cites·27 claims
- 4866US2017100490A1Prodrug Comprising a Drug Linker ConjugateASCENDIS PHARMA AS·Filed 2016·Application pending·0 cites
- 4966US2021283264A1Polymeric Prodrugs with a Self-Immolative LinkerASCENDIS PHARMA GMBH·Filed 2021·Application pending·0 cites
- 5066US2021069339A1Cnp prodrugsASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2020·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →